Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Nov 15, 2022 2:16pm
91 Views
Post# 35100792

RE:RE:RE:RE:RE:RE:No additional financing Yet

RE:RE:RE:RE:RE:RE:No additional financing Yet

a few past miss steps?

way more than a few

how long has this been at 6-8 cents

no one is shorting this or has been for months and months

the shorting excuse is bs

they did something that was out of the blue and no one likes it

could it turn around?  Maybe  I hope so for the suckers that stood behind this ceo and company which I am positive none of you did  you all sold out and bought back in now are starting to pump again  

they made even less money this time than last  why is that

they have no revenue from Aristotle  why is that  are they giving them away for free?


LithLover wrote: Agreed.  I'll be feeding the tfsa as well.  Even at $4-5 million a year in revenue the company should be valued at $20-25 million right now.  Market cap is half of that. 

The shorters have had their way until now but that will turn as they don't need to deal with the devil anymore.  

So post a way about the past missteps or missed opportyunities (I don't disagree there have been some) but you can see there is no sell off and in fact bids are building. 

Going to be fun when the announcements and partnerships are announced.  



 

<< Previous
Bullboard Posts
Next >>